Effect of inhibitors of GABA transaminase on the synthesis, binding, uptake, and metabolism of GABA.

Abstract

Abstract: Four catalytic inhibitors of GABA aminotransferase (gabaculine, γ‐acetylenic GABA, γ‐vinyl GABA, ethanolamine O‐sulphate) as well as aminooxyacetic acid and valproate were studied for effects on neurochemical assays for GABA synthesis, receptor binding, uptake and metabolism in mouse and rat brain preparations. Gabaculine did not interfere with GABA synthesis as reflected by the activity of glutamate decarboxylase (GAD), it was only a weak inhibitor (IC50= 0.94 mM) of GABA receptor binding sites but was a moderately potent inhibitor of GABA uptake (IC50= 81 μM) and very potent (IC50= 1.8 μM) with respect to inhibition of the GABA‐metabolizing enzyme GABA aminotransferase (GABA‐T). γ‐Acetylenic GABA was a weak inhibitor of GAD and GABA binding (IC50 > 1 mM), but virtually equipotent to inhibit uptake and metabolism of GABA (IC50 560 and 150 μM, respectively). This was very similar to γ‐vinyl GABA, except that this drug did not decrease GAD activity. Ethanolamine O‐sulphate was found to show virtually no inhibition of GAD and GABA uptake, but was a fairly potent inhibitor of GABA binding (IC50= 67 μM) and in this respect, 500 times more potent than as an inhibitor of GABA‐T. Aminooxyacetic acid was a powerful inhibitor of both GAD and GABA‐T (IC50 14 and 2.7 μM, respectively), but had very little affinity to receptor and uptake sites for GABA. Valproate showed no effects on GABA neurochemical assays which could be related to anticonvulsant action. The present results suggest that the anticonvulsant properties of the four catalytic inhibitors of GABA‐T tested are at least in part mediated through a direct influence on GABA receptors and uptake sites.